Chauquet S

No ORCID on file · 1 paper in corpus · active 2026

Study types

  • preprint 1
preprint 2026
Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.
·doi:10.21203/rs.3.rs-8096027/v1

Abstract Progestins are important first line and adjuvant medications for endometriosis, yet their efficacy varies among patients. Dienogest (DNG), a 4th generation progestin, is one of the most prescribed and successful progestins, althou…